1 |
Bodnar RJ. Endogenous opiates and behavior: 2014. Peptides 2016;75:18-70. [PMID: 26551874 DOI: 10.1016/j.peptides.2015.10.009] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 7.6] [Reference Citation Analysis]
|
2 |
Frigyesi A, Boström L, Lengquist M, Johnsson P, Lundberg OHM, Spångfors M, Annborn M, Cronberg T, Nielsen N, Levin H, Friberg H. Plasma proenkephalin A 119-159 on intensive care unit admission is a predictor of organ failure and 30-day mortality. Intensive Care Med Exp 2021;9:36. [PMID: 34278538 DOI: 10.1186/s40635-021-00396-6] [Reference Citation Analysis]
|
3 |
Zhang Z, Yu J, Wang P, Lin L, Liu R, Zeng R, Ma H, Zhao Y. iTRAQ-based proteomic profiling reveals protein alterations after traumatic brain injury and supports thyroxine as a potential treatment. Mol Brain 2021;14:25. [PMID: 33504361 DOI: 10.1186/s13041-021-00739-0] [Reference Citation Analysis]
|
4 |
Thorgeirsdóttir B, Levin H, Spångfors M, Annborn M, Cronberg T, Nielsen N, Lybeck A, Friberg H, Frigyesi A. Plasma proenkephalin A 119-159 and dipeptidyl peptidase 3 on admission after cardiac arrest help predict long-term neurological outcome. Resuscitation 2021;163:108-15. [PMID: 33930500 DOI: 10.1016/j.resuscitation.2021.04.021] [Reference Citation Analysis]
|